Lots of considerations when evaluating the FujiLAM assay - Author's reply
Lancet Glob Health
.
2023 Apr;11(4):e502.
doi: 10.1016/S2214-109X(23)00115-8.
Authors
Helena Huerga
1
,
Ankur Gupta-Wright
2
,
Winnie Muyindike
3
,
Catherine Hewison
4
,
Martina Casenghi
5
,
Maryline Bonnet
6
Affiliations
1
Department of Field Epidemiology, Epicentre, Paris 75019, France. Electronic address: helena.huerga@epicentre.msf.org.
2
Institute for Global Health, University College London, London, UK.
3
Department of Medicine, Mbarara Regional Referral Hospital, Mbarara, Uganda.
4
Department of Medicine, Médecins Sans Frontières, Paris, France.
5
Department of Innovation and New Technology, Elizabeth Glaser Pediatric AIDS Foundation, Geneva, Switzerland.
6
Université de Montpellier, TransVIHMI, INSERM, IRD, Montpellier, France.
PMID:
36925168
DOI:
10.1016/S2214-109X(23)00115-8
No abstract available
Publication types
Letter
Comment